Launch of the AVACEN medical device for the behavior management of autism spectrum disorders in Hong Kong


SAN DIEGO, 22 january 2018 / PRNewswire / – AVACEN Medical, Inc. (AVACEN) Announced the Launch of Sales of its AVACEN 100, an FDA Approved CE Marked Class II Dry Heat Therapy Medical Device, in Hong Kong to Address the Challenge of Behavioral Management of Autism Spectrum Disorders (TSA).

Hong Kong is home to 25,000 registered autistic children, according to the Autism Children Foundation.

According to a 2017 article published in the South China Morning Post, “Sandra Tsang Kit-man, associate professor at the Hong Kong University Department of Social Work and Social Administration, expects more than 10,000 schoolchildren to be diagnosed with autism in 2017-18, up from 7,200 in 2015-16. “

This has a devastating impact on those with autism and their personal support systems. In addition, autism places a heavy economic burden on public and private health care providers.

Thomas G Muehlbauer, CEO of AVACEN Medical said: “When we launch, we will reduce the normal price of AVACEN 100 by $ 2995 To $ 1495 for devices, ordered by families with autistic children, which are shipped to Hong Kong. In return, for the lower price, families must commit to completing a daily journal describing their child’s progress at home and at school during the 60-day trial repayment period. They will also be asked to submit a 10-minute video clip for analysis before and after the 60-day trial. to obtain approval to treat ASD behavior using AVACEN 100 in the United States “

The success of managing the behavior of ASDs related to the use of AVACEN 100 has been reported for years by parents who first bought the device for themselves and then gave it to their parents to try it out. children with ASD. Improvements range from speech impairments that go away quickly, to increased class participation and enthusiastic completion of homework. These encouraging developments were also accompanied by a surge in school grades from D to A and B in just a few months.

According to Gavin Wiswell, a health framework of San Marcos California, “In the first two weeks of using the AVACEN 100 device for 30 minutes, twice a day, my 6 year old son shocked us by reading a children’s book he had never read before; through and through, out loud, using his finger to point and perfectly pronounce each word. He usually recited them to us from memory, so this was a major step forward for our son! “

With approximately 3 million treatments and no reported side effects, AVACEN 100 is the only known medical device capable of rapidly warming the body safely and non-invasively by infusing into the circulatory system using the palm of the hand. .

The mechanism of action of AVACEN 100 is believed to mimic the effects of moderate fever. For over 30 years, moderate fever has been recognized as a catalyst to normalize children with autism for days or even weeks. [1] [2]. The company believes this explains why daily use of AVACEN 100 produces a continued normalization of certain aspects of ASD behavior.

About AVACEN 100 Patents

The US Patent Office has granted 4 patents to AVACEN. The patents cover innovations incorporated into the AVACEN 100 system, which is expected to provide multiple therapeutic uses to alleviate symptoms associated with circulatory, neurological, lymphatic or endocrine dysfunction, or any combination thereof. Patents have also been issued for China, Australia, Japan, UK, France, Germany, Spain, Sweden and Canada. Patents are pending in other countries.

On AVACEN Medical

AVACEN Medical is headquartered in San Diego and is dedicated to innovating and designing safe, easy-to-use and non-invasive drug-free alternatives for the management of pain associated with many chronic and acute conditions. Contact: Ryan jeffcoat at (888) 428-2236 ext. 711 or [email protected].

EU and Health Canada approval: A heat therapy system indicated for the temporary relief of minor muscle and joint pain and stiffness; temporary relief of joint pain associated with arthritis, muscle spasms, minor strains and sprains; temporary relief from the generalized pain associated with fibromyalgia; muscle relaxation; and the temporary increase in microcirculation.

US FDA-Authorisation: A heat therapy system indicated for the temporary relief of minor muscle and joint pain and stiffness; temporary relief of joint pain associated with arthritis; muscle spasms; minor strains and sprains; muscle relaxation; and the temporary increase in local traffic if necessary.

IMPORTANT: When there are regulatory restrictions relating to medical devices; tThe AVACEN 100 is not for sale in any country for any unauthorized or unapproved indication mentioned in this document.

[1] Cotterill RMJ. Fever in autistic people. Nature 1985; 313: 426.

[2] Brown G. The son sometimes. Humanist 1999; 59: 46e7. Consulted in 2012 on:


Related links


Leave A Reply